Anne Suzanne Bertens1,2, Justine E F Moonen2, Margot W M de Waal3, Jessica C Foster-Dingley2, Wouter de Ruijter3, Jacobijn Gussekloo3, Roos C van der Mast2,4, Anton J M de Craen5. 1. Department of Radiology, Leiden University Medical Centre, Leiden, the Netherlands. 2. Department of Psychiatry, Leiden University Medical Centre, Leiden, the Netherlands. 3. Department of Public Health and Primary Care, Leiden University Medical Centre, Leiden, the Netherlands. 4. Department of Psychiatry, CAPRI-University of Antwerp, Antwerp, Belgium. 5. Department of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, the Netherlands.
Abstract
OBJECTIVE: The Geriatric Depression Scale (GDS)-3A, a three-item subset of the GDS-15, is increasingly used as a measure for apathy in research settings to assess factors associating with this neuropsychiatric syndrome. We aimed to assess how accurately the GDS-3A discriminates between presence and absence of apathy in two populations of community-dwelling older persons, using the Apathy Scale as reference standard. METHODS: Baseline data were used from 427 participants of the Discontinuation of Antihypertensive Treatment in Elderly people (DANTE) Study Leiden and 1118 participants of the PROactive Management Of Depression in the Elderly (PROMODE) Study, all ≥75 years and with available GDS-3A and Apathy Scale measurements. A cut-off score of ≥14 was used for presence of apathy according to the Apathy Scale. Areas under the receiver operating characteristic curve (AUC) were calculated. Based on the likelihood ratios for GDS-3A scores, a cut-off of ≥2 was used for presence of apathy according to the GDS-3A to calculate test characteristics. RESULTS: The AUC was 0.68 (95% confidence interval 0.62-0.73) in the DANTE Study and 0.72 (0.67-0.77) in the PROMODE Study. In the DANTE Study sensitivity was 29.3% (21.4-38.1) and specificity was 88.5% (84.4-91.8), whereas in the PROMODE Study sensitivity was 32.8% (24.5-41.1) and specificity 92.6% (90.9-94.2). Stratification on population characteristics did not yield more favourable test characteristics. CONCLUSION: The GDS-3A has low sensitivity and high specificity as a measure of apathy in two populations of older persons. Using the GDS-3A in research might yield estimates biassed towards the null in case of non-differential misclassification.
OBJECTIVE: The Geriatric Depression Scale (GDS)-3A, a three-item subset of the GDS-15, is increasingly used as a measure for apathy in research settings to assess factors associating with this neuropsychiatric syndrome. We aimed to assess how accurately the GDS-3A discriminates between presence and absence of apathy in two populations of community-dwelling older persons, using the Apathy Scale as reference standard. METHODS: Baseline data were used from 427 participants of the Discontinuation of Antihypertensive Treatment in Elderly people (DANTE) Study Leiden and 1118 participants of the PROactive Management Of Depression in the Elderly (PROMODE) Study, all ≥75 years and with available GDS-3A and Apathy Scale measurements. A cut-off score of ≥14 was used for presence of apathy according to the Apathy Scale. Areas under the receiver operating characteristic curve (AUC) were calculated. Based on the likelihood ratios for GDS-3A scores, a cut-off of ≥2 was used for presence of apathy according to the GDS-3A to calculate test characteristics. RESULTS: The AUC was 0.68 (95% confidence interval 0.62-0.73) in the DANTE Study and 0.72 (0.67-0.77) in the PROMODE Study. In the DANTE Study sensitivity was 29.3% (21.4-38.1) and specificity was 88.5% (84.4-91.8), whereas in the PROMODE Study sensitivity was 32.8% (24.5-41.1) and specificity 92.6% (90.9-94.2). Stratification on population characteristics did not yield more favourable test characteristics. CONCLUSION: The GDS-3A has low sensitivity and high specificity as a measure of apathy in two populations of older persons. Using the GDS-3A in research might yield estimates biassed towards the null in case of non-differential misclassification.
Authors: Lisa Sm Eurelings; Jan Willem van Dalen; Gerben Ter Riet; Eric P Moll van Charante; Edo Richard; Willem A van Gool; Osvaldo P Almeida; Tiago S Alexandre; Bernhard T Baune; Horst Bickel; Francesco Cacciatore; Cyrus Cooper; Ton Ajm de Craen; Jean-Marie Degryse; Mauro Di Bari; Yeda A Duarte; Liang Feng; Nicola Ferrara; Leon Flicker; Maurizio Gallucci; Antonio Guaita; Stephanie L Harrison; Mindy J Katz; Maria L Lebrão; Jason Leung; Richard B Lipton; Marta Mengoni; Tze Pin Ng; Truls Østbye; Francesco Panza; Letizia Polito; Dirk Sander; Vincenzo Solfrizzi; Holly E Syddall; Roos C van der Mast; Bert Vaes; Jean Woo; Kristine Yaffe Journal: Clin Epidemiol Date: 2018-04-04 Impact factor: 4.790
Authors: Lonneke Wouts; Marco van Kessel; Aartjan T F Beekman; Radboud M Marijnissen; Richard C Oude Voshaar Journal: Int J Geriatr Psychiatry Date: 2019-10-30 Impact factor: 3.485
Authors: Anne Suzanne Bertens; Jessica C Foster-Dingley; Jeroen van der Grond; Justine E F Moonen; Roos C van der Mast; Nathaly Rius Ottenheim Journal: J Am Geriatr Soc Date: 2020-04-30 Impact factor: 5.562
Authors: Jan Willem van Dalen; Lennard L Van Wanrooij; Eric P Moll van Charante; Edo Richard; Willem A van Gool Journal: Neurology Date: 2017-12-01 Impact factor: 9.910
Authors: Mirnova E Ceïde; Alana Warhit; Emmeline I Ayers; Gary Kennedy; Joe Verghese Journal: J Gerontol B Psychol Sci Soc Sci Date: 2020-08-13 Impact factor: 4.077